137 related articles for article (PubMed ID: 12606622)
1. Melphalan antitumor efficacy and hepatotoxicity: the effect of variable infusion duration in the hepatic artery.
Rothbarth J; Woutersen RA; Sparidans RW; van de Velde CJ; Mulder GJ
J Pharmacol Exp Ther; 2003 Jun; 305(3):1098-103. PubMed ID: 12606622
[TBL] [Abstract][Full Text] [Related]
2. Reduced liver uptake of arterially infused melphalan during retrograde rat liver perfusion with unaffected liver tumor uptake.
Rothbarth J; Sparidans RW; Beijnen JH; Schultze-Kool LJ; Putter H; van de Velde CJ; Mulder GJ
J Pharmacol Exp Ther; 2002 Nov; 303(2):736-40. PubMed ID: 12388659
[TBL] [Abstract][Full Text] [Related]
3. Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: a clinical and pharmacologic evaluation.
van Iersel LB; Verlaan MR; Vahrmeijer AL; van Persijn van Meerten EL; Tijl FG; Sparidans RW; Gelderblom H; Kuppen PJ; Tollenaar RA; van de Velde CJ
Eur J Surg Oncol; 2007 Sep; 33(7):874-81. PubMed ID: 17400422
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological evaluation of experimental isolated liver perfusion and hepatic artery infusion with 5-fluorouracil.
de Brauw LM; Marinelli A; van de Velde CJ; Hermans J; Tjaden UR; Erkelens C; de Bruijn EA
Cancer Res; 1991 Mar; 51(6):1694-700. PubMed ID: 1998960
[TBL] [Abstract][Full Text] [Related]
5. Lack of glutathione conjugation of melphalan in the isolated in situ liver perfusion in humans.
Vahrmeijer AL; Snel CA; Steenvoorden DP; Beijnen JH; Pang KS; Schutrups J; Tirona R; Keizer HJ; van Dierendonck JH; van de Velde CJ; Mulder GJ
Cancer Res; 1996 Oct; 56(20):4709-14. PubMed ID: 8840988
[TBL] [Abstract][Full Text] [Related]
6. Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver.
Alexander HR; Libutti SK; Pingpank JF; Steinberg SM; Bartlett DL; Helsabeck C; Beresneva T
Clin Cancer Res; 2003 Dec; 9(17):6343-9. PubMed ID: 14695133
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antitumor effects of histamine plus melphalan in isolated hepatic perfusion for liver metastases.
Brunstein F; Eggermont AM; de Wiel-Ambagtsheer Ga; van Tiel ST; Rens J; ten Hagen TL
Ann Surg Oncol; 2007 Feb; 14(2):795-801. PubMed ID: 17096052
[TBL] [Abstract][Full Text] [Related]
8. Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model.
Glehen O; Stuart OA; Mohamed F; Sugarbaker PH
Cancer Chemother Pharmacol; 2004 Jul; 54(1):79-84. PubMed ID: 15048586
[TBL] [Abstract][Full Text] [Related]
9. Regional differences of melphalan lung levels after isolated lung perfusion in the rat.
Romijn S; Hendriks JM; Van Putte BP; Weyler J; Guetens G; De Boeck G; Van Schil PE
J Surg Res; 2005 May; 125(2):157-60. PubMed ID: 15854668
[TBL] [Abstract][Full Text] [Related]
10. Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer.
Bouchahda M; Adam R; Giacchetti S; Castaing D; Brezault-Bonnet C; Hauteville D; Innominato PF; Focan C; Machover D; Lévi F
Cancer; 2009 Nov; 115(21):4990-9. PubMed ID: 19637365
[TBL] [Abstract][Full Text] [Related]
11. Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion.
Marinelli A; van Dierendonck JH; van Brakel GM; Irth H; Kuppen PJ; Tjaden UR; van de Velde CJ
Br J Cancer; 1991 Dec; 64(6):1069-75. PubMed ID: 1764369
[TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
Kemeny NE; Niedzwiecki D; Hollis DR; Lenz HJ; Warren RS; Naughton MJ; Weeks JC; Sigurdson ER; Herndon JE; Zhang C; Mayer RJ
J Clin Oncol; 2006 Mar; 24(9):1395-403. PubMed ID: 16505413
[TBL] [Abstract][Full Text] [Related]
13. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
[TBL] [Abstract][Full Text] [Related]
14. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.
Guthoff I; Lotspeich E; Fester C; Wallin I; Schatz M; Ehrsson H; Kornmann M
Anticancer Res; 2003; 23(6D):5203-8. PubMed ID: 14981990
[TBL] [Abstract][Full Text] [Related]
15. Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases.
van Etten B; de Wilt JH; Brunstein F; Eggermont AM; Verhoef C
Eur J Surg Oncol; 2009 May; 35(5):539-45. PubMed ID: 18760560
[TBL] [Abstract][Full Text] [Related]
16. Isolated lung perfusion with melphalan: pharmacokinetics and toxicity in a pig model.
van der Elst A; Oosterling SJ; Paul MA; Vonk AM; Sparidans RW; van der Sijp JR
J Surg Oncol; 2006 Apr; 93(5):410-6. PubMed ID: 16550578
[TBL] [Abstract][Full Text] [Related]
17. [Concentration of 5-FU after hepatic artery infusion chemotherapy for liver metastases of colorectal cancer].
Maruyama S; Ando M; Watayo T
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1635-8. PubMed ID: 14619482
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion.
de Wilt JH; ten Hagen TL; de Boeck G; van Tiel ST; de Bruijn EA; Eggermont AM
Br J Cancer; 2000 Mar; 82(5):1000-3. PubMed ID: 10737379
[TBL] [Abstract][Full Text] [Related]
19. Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal "liver-only" metastases: hepatic interstitial brachytherapy plus regional chemotherapy.
Wieners G; Pech M; Hildebrandt B; Peters N; Nicolaou A; Mohnike K; Seidensticker M; Sawicki M; Wust P; Ricke J
Cardiovasc Intervent Radiol; 2009 Sep; 32(5):937-45. PubMed ID: 19472000
[TBL] [Abstract][Full Text] [Related]
20. [Hepatic arterial infusion of low-dose leucovorin/5-FU chemotherapy for unresectable hepatic metastases from colorectal cancer].
Fujimoto T; Yoshimatsu K; Yokomizo H; Umehara A; Watanabe K; Ohtani T; Matsumoto A; Ohsawa G; Ishibashi K; Ogawa K
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1838-40. PubMed ID: 17212122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
